YourUpdateTV speaks with Mia Syn: FALL FAMILY RESET: EASY NUTRITION & LIFESTYLE STRATEGIES TO KEEP FAMILIES THRIVING ALL SEASON LONG MS, RDN, Author and Nutrition Expert, Mia Syn, Shares Tips to Create a Fall Wellness Plan that Supports Both Body and Home GlobeNewswire October 28, 2025 Mia Syn, MS, RDN, and Nutrition Expert partners with […]
CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Q3-2025 GlobeNewswire October 28, 2025 Katy, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) — CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors unaudited financial results for Q3-2025. Key Financial Highlights for
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 28, 2025 WATERTOWN, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third quarter 2025 financial results on
Sitryx presents new preclinical data highlighting MTHFD2 as a novel metabolic target in autoimmune disease at ACR Convergence 2025 GlobeNewswire October 28, 2025 Preclinical data highlight MTHFD2 as a promising metabolic target in autoimmune disease, providing strong validation for the advancement of SIT-047, Sitryx's MTHFD2 inhibitor program, into clinical development SIT-047, with first-in-class potential as
Amphista Therapeutics to showcase how its Targeted Glue(TM) technology is expanding the diversity of TPD medicines at the 8th Annual TPD & Induced Proximity Summit 2025 GlobeNewswire October 28, 2025 Presentation will showcase the novel mechanisms of degradation of Amphista's Targeted Glues(TM), which recruit diverse E3 ligases, including DCAF16 and FBXO22, expanding the diversity and
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board GlobeNewswire October 28, 2025 AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia across multiple novel modalities Includes immunotherapies and small molecule drugs targeting intracellular proteinopathies Leadership
Qorvo(R) Announces Preliminary Fiscal 2026 Second Quarter Financial Results GlobeNewswire October 28, 2025 GREENSBORO, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) — Qorvo(R) (Nasdaq:QRVO), a leading global provider of connectivity and power solutions, today announced preliminary financial results for Qorvo's fiscal 2026 second quarter ended September 27, 2025. On a GAAP basis, preliminary financial results for
Kaixin Holdings Announces Intended Acquisition of Honglu Technology to Optimize AI Applications GlobeNewswire October 28, 2025 BEIJING, Oct. 28, 2025 (GLOBE NEWSWIRE) — Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) today announced the signing of a term sheet to acquire Honglu Technology, a leading Chinese AI animation company. Kaixin plans to issue new shares
Safe and Green Holdings Announces Its 2025 Record Date and Annual Shareholders Meeting Date GlobeNewswire October 28, 2025 CONROE, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) — via IBN — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green” or the “Company”) today announces that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”)
AOI Announces Expansion in the City of Sugar Land When Complete, AOI Will Have the Largest Production Capacity for AI-focused Datacenter Transceivers in the U.S. GlobeNewswire October 28, 2025 SUGAR LAND, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) — The City of Sugar Land, together with Applied Optoelectronics Inc. (Nasdaq: AAOI), a leading provider of advanced